EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy

Huimin Kong, Ke Yi, Yuxin Huang, Chunxiong Zheng iD, Yu Tao iD, Mingqiang Li iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c02161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nano Letters, 2026. Verfasst von Huimin Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou51063…. Hauptthemen laut MEDLINE: Genetic Therapy, Cell- and Tissue-Based Therapy. Die Arbeit nennt 88 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Primary Health Care Foundation, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inspired by natural membrane-fusion processes, membrane-fusogenic nanoparticles have emerged as a versatile platform for precise and efficient therapeutic delivery. By fusing directly with target cells, these systems efficiently transfer encapsulated bioactive cargo into the cytoplasm while bypassing endosomal entrapment. Simultaneously, the fusion process enables direct membrane engineering by integrating functional agents into the cell surface through lipid mixing. Leveraging this dual capability, membrane-fusogenic nanoparticles are evolving from simple gene delivery vehicles to versatile tools for cell engineering. In this Mini-Review, we highlight recent advances that position these nanoparticles as a unified platform bridging gene therapy and cell therapy. We outline the design principles and fusion-inducing mechanisms of current membrane-fusogenic nanoparticles and then discuss recent developments in programmable functionalization for gene and cell therapies. Finally, we address current challenges and future perspectives, offering insights into guiding the further optimization and clinical translation of these systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyCell- and Tissue-Based TherapyNanoparticlesLiposomesLigandsBiomimeticsHumansAnimalsCell Line, TumorCell Engineering

Stichwörter der Autor:innen

Membrane fusionbiomimetic nanoparticlecell engineeringgene delivery

Substanzen

LiposomesLigands

Autor:innen und Institutionen

  • Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou510630, China.
  • The First Affiliated Hospital, Guangzhou Medical University, Guangzhou510120, China.
  • School of Chemistry, South China Normal University, Guangzhou510006, China.
  • Cell-Gene Therapy Center, Institute for Frontier Interdisciplinary Research in Health Sciences and Technology, Sun Yat-sen University, Guangzhou510080, China.
  • Key Laboratory for Polymeric Composite and Functional Materials of the Ministry of Education, Sun Yat-sen University, Guangzhou510275, China.

ORCID-Profile: Chunxiong Zheng, Yu Tao, Mingqiang Li

Förderung

  • National Natural Science Foundation of China
  • China Primary Health Care Foundation
  • National Key Research and Development Program of China
  • Science and Technology Program of Guangzhou
  • Natural Science Foundation of Guangdong Province for Distinguished Young Scholar
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Kong, H., Yi, K., Huang, Y., Zheng, C., Tao, Y., & Li, M. (2026). Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02161

Vancouver

Kong H, Yi K, Huang Y, Zheng C, Tao Y, Li M. Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02161

BibTeX
@article{Kong2026,
  author = {Kong, Huimin and Yi, Ke and Huang, Yuxin and Zheng, Chunxiong and Tao, Yu and Li, Mingqiang},
  title = {Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c02161}
}
Kostenlos starten →